Schroder Investment Management Group Has $19.62 Million Stock Position in Novanta Inc. $NOVT

Schroder Investment Management Group cut its stake in Novanta Inc. (NASDAQ:NOVT) by 11.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 196,049 shares of the technology company’s stock after selling 24,789 shares during the period. Schroder Investment Management Group’s holdings in Novanta were worth $19,615,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in NOVT. Dynamic Technology Lab Private Ltd lifted its position in shares of Novanta by 94.0% in the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 11,696 shares of the technology company’s stock worth $1,171,000 after purchasing an additional 5,666 shares during the period. Barclays PLC increased its position in shares of Novanta by 14.8% during the third quarter. Barclays PLC now owns 89,925 shares of the technology company’s stock worth $9,006,000 after buying an additional 11,619 shares during the period. Dimensional Fund Advisors LP raised its stake in Novanta by 1.8% during the third quarter. Dimensional Fund Advisors LP now owns 594,936 shares of the technology company’s stock worth $59,582,000 after buying an additional 10,295 shares during the last quarter. Victory Capital Management Inc. raised its stake in Novanta by 4.5% during the third quarter. Victory Capital Management Inc. now owns 148,113 shares of the technology company’s stock worth $14,834,000 after buying an additional 6,426 shares during the last quarter. Finally, Segall Bryant & Hamill LLC lifted its holdings in Novanta by 2.5% in the third quarter. Segall Bryant & Hamill LLC now owns 103,583 shares of the technology company’s stock valued at $10,374,000 after buying an additional 2,529 shares during the period. Institutional investors and hedge funds own 98.35% of the company’s stock.

Novanta Stock Performance

NASDAQ:NOVT opened at $119.54 on Friday. The company has a quick ratio of 2.80, a current ratio of 3.69 and a debt-to-equity ratio of 0.16. Novanta Inc. has a twelve month low of $98.27 and a twelve month high of $149.95. The company has a fifty day moving average of $135.17 and a 200-day moving average of $121.16. The firm has a market capitalization of $4.27 billion, a P/E ratio of 81.88 and a beta of 1.61.

Novanta (NASDAQ:NOVT) last issued its earnings results on Monday, February 23rd. The technology company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.88 by $0.03. The business had revenue of $258.35 million for the quarter, compared to analyst estimates of $260.72 million. Novanta had a net margin of 5.49% and a return on equity of 13.12%. During the same period in the prior year, the firm earned $0.76 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. As a group, sell-side analysts anticipate that Novanta Inc. will post 3.03 EPS for the current year.

Insider Activity

In other news, CEO Matthijs Glastra sold 7,500 shares of the stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $145.04, for a total transaction of $1,087,800.00. Following the transaction, the chief executive officer owned 57,367 shares of the company’s stock, valued at $8,320,509.68. This represents a 11.56% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Robert Buckley sold 1,423 shares of the firm’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $140.88, for a total value of $200,472.24. Following the completion of the sale, the chief financial officer owned 93,814 shares of the company’s stock, valued at approximately $13,216,516.32. This represents a 1.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 24,346 shares of company stock worth $3,382,737 in the last quarter. Company insiders own 1.20% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on NOVT shares. Zacks Research raised shares of Novanta from a “strong sell” rating to a “hold” rating in a research report on Friday, January 16th. Weiss Ratings raised Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, January 20th. Finally, Robert W. Baird set a $150.00 price objective on Novanta in a research note on Wednesday, February 25th. Three research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $150.00.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.